Australian Pharmaceutical Industries Ltd (API.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 08-2016 | 08-2015 | 08-2014 | 08-2013 | 08-2012 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,302 | -7,343 | -9,235 | -18,092 | -18,608 |
| Net Acquisitions | 4,361 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -5,128 | -22,600 | -19,263 | -6,223 | -215 |
| Other Investing Activity | 0 | 84 | 1,820 | 400 | -5,554 |
| Investing Cash Flow | $-13,069 | $-29,859 | $-26,678 | $-23,915 | $-24,377 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,327,196 | N/A | N/A | 277 | 6,335 |
| Debt Repayment | -1,374,147 | -7,155 | -486 | N/A | N/A |
| Dividend Paid | -24,430 | -19,525 | -15,864 | -14,643 | -14,643 |
| Other Financing Activity | -1,455 | -19,057 | -20,363 | -25,577 | -30,118 |
| Financing Cash Flow | $-72,836 | $-45,737 | $-36,713 | $-39,943 | $-38,426 |
| Exchange Rate Effect | 490 | 61 | 153 | 285 | -69 |
| Beginning Cash Position | 28,047 | 23,526 | 22,576 | 19,549 | 34,605 |
| End Cash Position | 25,489 | 28,047 | 23,526 | 22,576 | 19,549 |
| Net Cash Flow | $-3,048 | $4,460 | $797 | $2,742 | $-14,987 |
| Free Cash Flow | |||||
| Capital Expenditure | -19,545 | -30,634 | -30,126 | -25,098 | -19,839 |
| Free Cash Flow | -19,545 | -30,634 | -30,126 | -25,098 | -19,839 |